Cidara Therapeutics, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
CDTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
6310 Nancy Ridge Drive, Suite 101, San Diego, CA

Insiders trading volume in the past year

Cidara Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. Director, 10%+ Owner $167M +$100M +149% Jun 26, 2025
Jeffrey Stein President & CEO, Director $1.12M Mar 31, 2025
Shane Ward Coo & Clo $871K -$36.5K -4.03% Mar 31, 2025
Frank Karbe Chief Financial Officer $857K Feb 24, 2025
Nicole Negar Davarpanah Chief Medical Officer $585K Sep 11, 2025
Leslie Tari Chief Scientific Officer $358K -$38.9K -9.82% Mar 11, 2025
Taylor Sandison Chief Medical Officer $268K Sep 30, 2024
Preetam Shah Chief Financial Officer $232K Sep 30, 2024
Paul Daruwala Chief Operating Officer $210K Sep 12, 2022
Chrysa Mineo Director $77.8K +$73.9K +1880% Jun 18, 2025
Brady Johnson Vice President, Finance $56.3K Mar 31, 2022
Theodore R. Schroeder Director Jun 18, 2025
Daniel D. Burgess Director Jun 18, 2025
Timothy R. Franson Director Jun 22, 2023
David L. Gollaher Director Jun 22, 2023
Carin Canale-Theakston Director Jun 18, 2025
Bonnie L. Bassler Director Jun 18, 2025
Joshua Resnick Director Jun 18, 2025
James Merson Director Jun 18, 2025
Ryan Spencer Director Jun 18, 2025
Laura Tadvalkar Director Jul 18, 2024

Recent Insider Transactions by Companies or Individuals for Cidara Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.